Venmax Drugs & Pharmaceuticals

quarterly
yearly
ParticularsSep '24Dec '24Mar '25Jun '25Sep '25
Revenue0.170.201.351.211.32
Expenses0.470.690.581.171.27
EBITDA-0.30-0.500.770.040.05
EBIT-0.30-0.500.770.040.05
Profit Before Tax-0.30-0.500.780.040.04
Net Profit-0.30-0.500.780.040.02
Financial Ratios
Operating Profit Margin-176.47%-245.00%236.36%3.31%3.79%
Net Profit Margin-176.47%-250.00%236.36%3.31%1.52%
Earning Per Share (Diluted)-0.58-0.951.490.070.05
Dividends Per Share0.000.000.000.000.00